CBChaobo Bai

Chaobo Bai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chaobo Bai has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Ran Meng

    Department of Neurology, Xuanwu Hospital Capital Medical University Beijing China

    2 shared publications
  • Baoyu Chen

    Department of Neurology Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University Beijing China

    1 shared publication
  • Danhua Zhao

    Department of Neurology Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University Beijing China

    1 shared publication
  • Jian Chen

    ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Jing Chen

    Department of Neurology, Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of China

    1 shared publication
  • Junliang Yuan

    Department of Neurology, Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Predictors for early‐onset psychotic symptoms in patients newly diagnosed with Parkinson's disease without psychosis at baseline: A 5‐year cohort study

    by Jing Chen, Baoyu Chen, Danhua Zhao, Xiaotong Feng, Qi Wang, Yuan Li, Junyi Chen, Chaobo Bai, Xintong Guo, Xiaoyu He, et al.

    Aims: To investigate the risk factors for early‐onset psychosis in Parkinson's disease (PD) in a cohort of patients from the Parkinson's Progression Markers Initiative.Methods: Longitudinal data on motor and non‐motor features, dopamine transporter (DAT) imaging, and cerebrospinal fluid (CSF) measurements were collected. The survival probability of psychotic symptoms, potential risk factors for psychosis development over a 5‐year follow‐up period, and the performance of the prediction model were evaluated.Results: Among the 338 newly diagnosed patients with PD, 83 developed psychotic symptoms. Gastrointestinal autonomic dysfunction, presence of probable rapid‐eye‐movement sleep behavior disorder, and the ratio Aβ42: total‐tau could independently predict onset of psychosis in PD (hazard ratio (HR) = 1.157, 95% confidence interval (CI) 1.022–1.309, p = 0.021, HR = 2.596, 95% CI 1.287–5.237, p = 0.008, and HR = 0.842, 95% CI 0.723–0.980, p = 0.027, respectively). The combined model integrating baseline clinical predictors, DAT imaging, and CSF measurements achieved better sensitivity than the clinical predictors alone (area under the curve = 0.770 [95% CI 0.672–0.868] vs. 0.714 [95% CI 0.625–0.802], p = 0.098).Conclusion: We identified clinical and CSF predictors of early‐onset psychosis in patients with PD. Our study provides evidence and implications for prognostic stratification and therapeutic approaches for PD psychosis.


  • Open Access

    Long‐term safety and efficacy of stenting on correcting internal jugular vein and cerebral venous sinus stenosis

    by Chaobo Bai, Zhiying Chen, Yuchuan Ding, Xunming Ji, Junliang Yuan, Ran Meng

    Objectives: To compare the long‐term safety and efficacy of stenting in correcting cerebral venous sinus stenosis (CVSS) and internal jugular venous stenosis (IJVS).Methods: Patients confirmed with CVSS or IJVS by imaging were enrolled in this real‐world study from 2014 through 2021. Clinical characteristics and long‐term outcomes of these two diseases entities post‐stenting were followed up and compared.Results: Three hundred and nineteen patients were enrolled in this study, with a mean age of 48.83 years and a BMI of 25.08 on average. In which, 144 patients underwent stenting, the stenotic segments were corrected and the venous blood flow was restored immediately post‐stenting. At 6.15 ± 1.67 days follow‐up, significant improvement was observed in headache, tinnitus, insomnia, ICP, and mean pressure gradient in both groups (allp < 0.05). At 30.53 ± 4.41 months follow‐up post‐stenting, the headache, tinnitus, visual loss, papilledema, and insomnia were attenuated remarkably or even completely disappeared. The Frisen papilledema grade scores declined from 2 (0–4) to 1 (0–3) in IJVS group and from 4 (1–5) to 1 (0–4) in CVSS group compared to the baseline. One hundred and twenty‐seven out of the 144 patients (95.5%) maintained sufficient blood flow verified by followed up computed tomographic venography or contrast‐enhanced magnetic resonance angiography. Adverse events related to stenting included three cases of intraluminal restenosis and three cases of in‐stent thrombosis, no intracranial hemorrhage, venous thromboembolisms, stent‐adjacent stenosis, and stent displacement occurred.Interpretation: Using stents to correct IH and related neurological issues has shown to be a safe and effective approach for both IJVS and CVSS.


  • Open Access

    Perioperative mannitol intensive use may avoid the early complication of cerebral venous sinus stenting

    by Chaobo Bai, Jian Chen, Xiaoqin Wu, Yuchuan Ding, Xunming Ji, Ran Meng

    Background: Cerebral venous sinus (CVS) stenting has been widely applied for correcting CVS stenosis. However, there are still some potential complications. The purpose of this study is to investigate the impact of perioperative management on avoiding complications of CVS stenting. Methods: Patients confirmed as CVS stenosis were enrolled from January 2014 through November 2019. All CVS stenosis were corrected by stenting when the trans-stenotic mean pressure gradient (MPG) was up to or over 8 mmHg. Patients were divided into perioperative management group and control group. Patients in the former group underwent transiently mannitol 250 mL intravenous infusion immediately prior to stenting besides routine ICP control. While patients in control group underwent the same routine treatment as in the perioperative management group. The clinical symptoms, intracranial pressure (ICP), and MPG of the patients were compared before and after stenting. In addition, the complications between the two groups were compared. Results: A total of 81 eligible patients were finally enrolled in this study, including 64 females and 17 males, mean aged 45.35±13.83 years. After stenting, the stenotic CVS restored normal blood flow and MPG decreased significantly [10.0 (8.0–15.0) vs. 0.0 (0.0–0.7) mmHg, Pvs. 0.0%, P=0.031). Conclusions: A transiently strict preoperative ICP control by mannitol may inhibit CVS stenting-related hemorrhage, which makes the stenting safer and more effective on correcting the CVS stenosis.